Abstract: Amorphous calcium phosphate (ACP) is a known precursor of apatite, which is one of the main components of human bone. Synthesized ACP transforms into low-crystallinity hydroxyapatite (HAp) around body temperature. Thus, if low-crystallinity calcium phosphate cement, containing active ingredients for bone repair, can be prepared at around 0ºC, it is expected to be a suitable material for the controlled-release of active ingredients. Sr was reported to promote a cytokine, which inhibited the formation of osteoclasts. Thus, Sr-doped ACP is expected to be a controlled-release material and can promote bone formation. In this study, we synthesized Sr-doped ACP powder by wet synthesis, and prepared Sr-doped calcium phosphate cement. The cement has potential for use as a new type of bone substitute.
INTRODUCTION
Calcium phosphates find clinical use as bone substitutes 1 . Amorphous calcium phosphate (ACP) is a known precursor of bone formation 2 . Synthesized ACP transforms into low-crystallinity hydroxyapatite (HAp) around body temperature and is one of the main constituents of human bone 3 . After the bone substitutes are implanted, the materials are incorporated in bone metabolism. Thus, if low-crystallinity calcium phosphate cements with active ingredients can be prepared at around 0ºC, they are expected to be a suitable material for the controlled-release of active ingredients. Certain elements are essential mineral nutrients. For example, Zn plays a critical role in bone formation 4, 5 . Materials that release therapeutic agents such as Zn in response to osteoclast activity are expected to be suitable controlled-release materials. Previously, we successfully synthesized Zn-doped calcium phosphate and evaluated its performance in bone disease and metabolism environments [6] [7] [8] . Trace elements present as dopants in the structure of calcium phosphate would be released continuously in bone metabolism.
In this study, we attempted to synthesize Sr-doped calcium phosphate powder by wet synthesis and to prepare cements from the powder. Sr was reported to promote a cytokine, which inhibited the formation of osteoclasts 9 . In addition, Sr is in the same group of the periodic table as Ca. Thus, Sr-doped calcium phosphate should be an easy to synthesize source material for the continuous release of Sr, in order to promote bone formation. The cement could therefore become a potential bone substitute.
MATERIALS AND METHODS
Calcium phosphate powder (CPpo) was prepared from 0.2 mol/dm 3 CaCl 2 ·2H 2 O and NaH 2 PO 4 solutions by wet synthesis. The solutions were mixed at a 1:1 molar ratio of Ca to P. The mixed solution was added to a 0.4 mol/dm 3 NaOH solution while stirring and maintained at a temperature less than 4ºC and a pH of 10. The precipitates were filtered, washed and freeze dried. The Sr-doped calcium phosphate powder (SrCPpo) was synthesized as follows. A mixed solution of CaCl 2 ·2H 2 O and SrCl 2 was added to a NaH 2 PO 4 solution with a molar ratio of (Ca+Sr)/P = 1.0 and Sr/(Ca+Sr) = 0.1, by the same wet synthesis.
Calcium phosphate cement samples were prepared as follows. First, 0.2 g of powder (either CPpo or SrCPpo) was added to a 0.02 mol/dm 3 H 3 PO 4 solution, mixed and then cast into acrylic pipe templates with an internal diameter of 6 mm. The cast slurry was pushed and formed using a Teflon rod. Finally, the cement samples were obtained by drying the slurries at 37ºC for 24 hours (CPce, SrCPce).
The crystalline phases of the synthesized powders and cement samples were measured using powder X-ray diffraction (XRD). The chemical groups were measured using Fourier transform infrared -21-spectroscopy (FT-IR). The Sr content and (Ca+Sr)/P molar ratio were calculated from the concentration of these elements in a nitric acid solution measured by inductively-coupled plasma atomic emission spectrometry (ICP-AES). The compressive mechanical strength of the cement samples was measured by a universal testing machine. The specimens of the compressive test conformed to the JIS R1608 standard. The crosshead speed was 5 mm/min. The porosity of the cement samples was calculated by the Archimedes principle. Five samples each were tested and measured by the compression and porosity tests. Powder morphology and cement cross-section observations, and surface elemental analysis of Ca, P, and Sr were undertaken by scanning electron microscopy (SEM) and energy-dispersive X-ray spectrometry (EDX).
RESULTS
Crystalline peaks were not detected in the XRD patterns of CPpo and SrCPpo ( Figure 1 ). The sample powders were therefore considered to be amorphous. Figure 2 shows the Sr molar ratios Sr/(Ca+Sr) (a) and (Ca+Sr)/P (b) calculated from ICP-AES measurements. The Sr content (9.44 mol%) of SrCPpo was almost the same as the initial composition. Both (Ca+Sr)/P values of CPpo and SrCPpo (1.87 and 1.77) were higher than that of the starting ratios. Figure 3 shows that peaks corresponding to low-crystallinity HAp were detected in the XRD patterns of both crushed CPce and SrCPce. The amorphous phase transformed into the crystalline phase during drying and setting and the Sr entered the crystal lattice. Figure 4 shows the FT-IR spectra of commercial HAp, CPce and SrCPce. Peaks at 850 cm -1 and 1450 cm -1 corresponding to CO 3 2-were detected in the CPce and SrCPce samples, but not the commercial HAp samples. Likewise, the 1700 cm -1 and broad 3500 cm -1 hydrate peaks were detected in the cement samples but not the commercial HAp samples.
Typical stress-strain curves of the cement samples resulting from the compression test are shown in Figure 5 . The compressive strength and Young's modulus from the compression test and the porosity derived using the Archimedes principle, are shown in Table 1 . The compressive strengths of CPce and SrCPce were about 6.6 and 5.0 MPa, respectively. The Young's moduli of CPce and SrCPce were about -22-0.72 and 0.57 GPa, respectively. The compressive strength and Young's modulus of CPce were higher than that of SrCPce. In accordance with the mechanical properties, the porosity of CPce was lower than that of SrCPce.
The morphology of CPpo and SrCPpo, and the cross sectional view of CPce and SrCPce are shown in Figure 6 . The EDX spectra and relative elemental concentration derived from EDX of these samples are shown in Figure 7 and Table 2 , respectively. The cement samples were formed through the adhesion between the precursor powders. A peak at 1.87 keV corresponding to Sr was detected in SrCPpo and SrCPce, but not in CPpo and CPce. SrCPce contained the same ratio of Sr as the starting powder. 
DISCUSSION
The XRD patterns of the powder samples revealed the successful preparation of Sr-doped amorphous calcium phosphate (SrCP) by a simple wet synthesis method. The SrCP powder included 10 mol% (Sr/(Ca+Sr) = 0.1) of Sr in accordance with the starting ratio. The prepared cement also contained Sr. It was easy for Sr to replace Ca in the calcium phosphate crystal structure because both elements are in the same group, have similar ionic radii and are congeners. The calcium phosphate phase was doped by Sr. The higher molar ratios of (Ca+Sr)/P in comparison to the starting composition could be attributed to the substitution of PO 4 3-by CO 3 2-in the calcium phosphate phase. During setting, the cement samples of CPce and SrCPce crystallized into a low-crystallinity HAp phase at body temperature. After preparing the cements, the CO 3 2-group and hydrated water were detected in the FT-IR spectra. Their existence, together with the low setting temperature (37ºC), accounts for the low crystallinity of the HAp phase. Therefore, the main crystal structure of SrCPce could be assigned to a Ca-deficient low-crystallinity carbonate apatite phase. The mechanical properties of CPce were superior to those of SrCPce. These properties would make the material suitable for handling during an operation and are comparable to those of cancellous bone 10 . Sr was only present as a dopant in the structure of the low-crystallinity HAp. Moreover, the addition of Sr does not affect the porosity of the cement. Thus, the Sr-doped calcium phosphates in this study can be expected to continuously release Sr in bone -23-metabolism environments.
CONCLUSION
We successfully prepared Sr-doped amorphous calcium phosphate powder and low-crystallinity Sr-doped HAp cement. The mechanical properties of the cement are sufficient for handling. Sr-doped HAp cement prepared from amorphous calcium phosphate is expected to be a potential material for the continuous release of active ingredients.
